AANP FNP CERTIFICATION LATEST 2023-
2024 WITH 200 EXAM QUESTIONS A
CORRECT ANSWERS(VERIFIED
SECTION 1: CARDIOVASCULAR CONDITIONS
Question 1
A 58-year-old male with a history of hypertension and type 2 diabetes presents for
follow-up. His current medications include lisinopril 20 mg daily, metformin 1000
mg BID, and atorvastatin 40 mg daily. His blood pressure today is 152/94 mmHg.
He has no complaints. According to the 2017 ACC/AHA guidelines, what is the
most appropriate next step in management?
A) Continue current therapy and reassess in 6 months
B) Add a thiazide diuretic or calcium channel blocker
C) Increase lisinopril to 40 mg daily
D) Refer to cardiology for resistant hypertension
Correct Answer: B) Add a thiazide diuretic or calcium channel blocker
Rationale: According to the 2017 ACC/AHA hypertension guidelines, for
patients with stage 2 hypertension (≥140/90 mmHg) who are already on
antihypertensive therapy but not at goal, the recommended approach is to add a
second agent from a different class rather than maximizing a single agent. This
patient has a BP of 152/94 mmHg, which is above goal (<130/80 mmHg for
patients with diabetes). Adding a thiazide diuretic (e.g., chlorthalidone) or a
calcium channel blocker (e.g., amlodipine) is the most appropriate step. Option A
is incorrect because the patient is not at goal. Option C (increasing lisinopril) is less
effective than adding a second agent. Option D is premature as the patient does
not yet meet criteria for resistant hypertension (requiring 3 agents including a
diuretic).
,Question 2
A 45-year-old female presents with palpitations and lightheadedness. ECG reveals
irregularly irregular rhythm with no discernible P waves and a ventricular rate of
138 bpm. She has no history of heart disease. Which of the following is the most
appropriate initial management strategy?
A) Immediate synchronized cardioversion
B) IV amiodarone
C) Rate control with beta-blocker or calcium channel blocker
D) Anticoagulation with warfarin and discharge
Correct Answer: C) Rate control with beta-blocker or calcium channel
blocker
Rationale: This patient has atrial fibrillation with rapid ventricular response. In
a hemodynamically stable patient (no hypotension, shock, or acute heart failure),
the initial management is rate control using a beta-blocker (e.g., metoprolol) or a
non-dihydropyridine calcium channel blocker (e.g., diltiazem). Synchronized
cardioversion (A) is indicated for hemodynamically unstable patients. IV
amiodarone (B) is used for rhythm control in specific situations but is not first-line
for rate control. Anticoagulation (D) is important for stroke prevention but does
not address the acute rate control issue, and the patient's CHA₂DS₂-VASc score
would need to be calculated to determine anticoagulation need.
Question 3
A 62-year-old male with a history of heart failure with reduced ejection fraction
(HFrEF, EF 30%) presents with worsening dyspnea and lower extremity edema. His
current medications include carvedilol, lisinopril, and furosemide. Which of the
following medications should be added to reduce mortality in this patient?
A) Amlodipine
B) Spironolactone
,C) Verapamil
D) Digoxin
Correct Answer: B) Spironolactone
Rationale: In patients with HFrEF (EF ≤35%) who remain symptomatic despite
optimal therapy with ACE inhibitors and beta-blockers, aldosterone receptor
antagonists (spironolactone or eplerenone) have been shown to reduce mortality
in major clinical trials (RALES, EMPHASIS-HF). Amlodipine (A) is a dihydropyridine
calcium channel blocker that does not improve mortality in HFrEF. Verapamil (C) is
a non-dihydropyridine calcium channel blocker that is contraindicated in HFrEF
due to negative inotropic effects. Digoxin (D) reduces hospitalizations but does not
reduce mortality.
Question 4
Which of the following are classic risk factors for the development of abdominal
aortic aneurysm (AAA)? (Select All That Apply)
A) Smoking
B) Male sex
C) Age >65 years
D) Hypertension
E) Female sex
Correct Answers: A) Smoking, B) Male sex, C) Age >65 years, D) Hypertension
Rationale: Classic risk factors for AAA include smoking (strongest risk factor),
male sex, age >65 years, hypertension, and a family history of AAA. Female sex (E)
is not a risk factor; in fact, AAA is more common in men. The USPSTF recommends
one-time ultrasound screening for AAA in men aged 65-75 who have ever smoked.
Question 5
, A 55-year-old female presents with chest pain that occurs at rest and is associated
with ST-segment elevation on ECG. Troponin is elevated. She is diagnosed with an
acute coronary syndrome. Which of the following is the most appropriate
immediate treatment?
A) Aspirin 325 mg chewed
B) Nitroglycerin sublingual
C) Morphine sulfate IV
D) All of the above
Correct Answer: D) All of the above
Rationale: For a patient with acute coronary syndrome (STEMI), the
immediate treatment includes aspirin (chewed for rapid absorption), nitroglycerin
(for chest pain and vasodilation), and morphine (for pain relief and anxiety
reduction). This combination is part of the initial management. However, it is
important to note that the patient should also be evaluated for reperfusion
therapy (PCI or thrombolytics) as the definitive treatment. All three options are
appropriate initial therapies.
Question 6
A 70-year-old male with a history of hypertension and atrial fibrillation on
warfarin presents with a 2-day history of dark, tarry stools. His INR is 5.8. Which of
the following is the most appropriate immediate management?
A) Continue warfarin and monitor
B) Administer vitamin K (phytonadione) and fresh frozen plasma (FFP) or
prothrombin complex concentrate (PCC)
C) Start a direct oral anticoagulant (DOAC)
D) Administer protamine sulfate
Correct Answer: B) Administer vitamin K (phytonadione) and fresh frozen
plasma (FFP) or prothrombin complex concentrate (PCC)
2024 WITH 200 EXAM QUESTIONS A
CORRECT ANSWERS(VERIFIED
SECTION 1: CARDIOVASCULAR CONDITIONS
Question 1
A 58-year-old male with a history of hypertension and type 2 diabetes presents for
follow-up. His current medications include lisinopril 20 mg daily, metformin 1000
mg BID, and atorvastatin 40 mg daily. His blood pressure today is 152/94 mmHg.
He has no complaints. According to the 2017 ACC/AHA guidelines, what is the
most appropriate next step in management?
A) Continue current therapy and reassess in 6 months
B) Add a thiazide diuretic or calcium channel blocker
C) Increase lisinopril to 40 mg daily
D) Refer to cardiology for resistant hypertension
Correct Answer: B) Add a thiazide diuretic or calcium channel blocker
Rationale: According to the 2017 ACC/AHA hypertension guidelines, for
patients with stage 2 hypertension (≥140/90 mmHg) who are already on
antihypertensive therapy but not at goal, the recommended approach is to add a
second agent from a different class rather than maximizing a single agent. This
patient has a BP of 152/94 mmHg, which is above goal (<130/80 mmHg for
patients with diabetes). Adding a thiazide diuretic (e.g., chlorthalidone) or a
calcium channel blocker (e.g., amlodipine) is the most appropriate step. Option A
is incorrect because the patient is not at goal. Option C (increasing lisinopril) is less
effective than adding a second agent. Option D is premature as the patient does
not yet meet criteria for resistant hypertension (requiring 3 agents including a
diuretic).
,Question 2
A 45-year-old female presents with palpitations and lightheadedness. ECG reveals
irregularly irregular rhythm with no discernible P waves and a ventricular rate of
138 bpm. She has no history of heart disease. Which of the following is the most
appropriate initial management strategy?
A) Immediate synchronized cardioversion
B) IV amiodarone
C) Rate control with beta-blocker or calcium channel blocker
D) Anticoagulation with warfarin and discharge
Correct Answer: C) Rate control with beta-blocker or calcium channel
blocker
Rationale: This patient has atrial fibrillation with rapid ventricular response. In
a hemodynamically stable patient (no hypotension, shock, or acute heart failure),
the initial management is rate control using a beta-blocker (e.g., metoprolol) or a
non-dihydropyridine calcium channel blocker (e.g., diltiazem). Synchronized
cardioversion (A) is indicated for hemodynamically unstable patients. IV
amiodarone (B) is used for rhythm control in specific situations but is not first-line
for rate control. Anticoagulation (D) is important for stroke prevention but does
not address the acute rate control issue, and the patient's CHA₂DS₂-VASc score
would need to be calculated to determine anticoagulation need.
Question 3
A 62-year-old male with a history of heart failure with reduced ejection fraction
(HFrEF, EF 30%) presents with worsening dyspnea and lower extremity edema. His
current medications include carvedilol, lisinopril, and furosemide. Which of the
following medications should be added to reduce mortality in this patient?
A) Amlodipine
B) Spironolactone
,C) Verapamil
D) Digoxin
Correct Answer: B) Spironolactone
Rationale: In patients with HFrEF (EF ≤35%) who remain symptomatic despite
optimal therapy with ACE inhibitors and beta-blockers, aldosterone receptor
antagonists (spironolactone or eplerenone) have been shown to reduce mortality
in major clinical trials (RALES, EMPHASIS-HF). Amlodipine (A) is a dihydropyridine
calcium channel blocker that does not improve mortality in HFrEF. Verapamil (C) is
a non-dihydropyridine calcium channel blocker that is contraindicated in HFrEF
due to negative inotropic effects. Digoxin (D) reduces hospitalizations but does not
reduce mortality.
Question 4
Which of the following are classic risk factors for the development of abdominal
aortic aneurysm (AAA)? (Select All That Apply)
A) Smoking
B) Male sex
C) Age >65 years
D) Hypertension
E) Female sex
Correct Answers: A) Smoking, B) Male sex, C) Age >65 years, D) Hypertension
Rationale: Classic risk factors for AAA include smoking (strongest risk factor),
male sex, age >65 years, hypertension, and a family history of AAA. Female sex (E)
is not a risk factor; in fact, AAA is more common in men. The USPSTF recommends
one-time ultrasound screening for AAA in men aged 65-75 who have ever smoked.
Question 5
, A 55-year-old female presents with chest pain that occurs at rest and is associated
with ST-segment elevation on ECG. Troponin is elevated. She is diagnosed with an
acute coronary syndrome. Which of the following is the most appropriate
immediate treatment?
A) Aspirin 325 mg chewed
B) Nitroglycerin sublingual
C) Morphine sulfate IV
D) All of the above
Correct Answer: D) All of the above
Rationale: For a patient with acute coronary syndrome (STEMI), the
immediate treatment includes aspirin (chewed for rapid absorption), nitroglycerin
(for chest pain and vasodilation), and morphine (for pain relief and anxiety
reduction). This combination is part of the initial management. However, it is
important to note that the patient should also be evaluated for reperfusion
therapy (PCI or thrombolytics) as the definitive treatment. All three options are
appropriate initial therapies.
Question 6
A 70-year-old male with a history of hypertension and atrial fibrillation on
warfarin presents with a 2-day history of dark, tarry stools. His INR is 5.8. Which of
the following is the most appropriate immediate management?
A) Continue warfarin and monitor
B) Administer vitamin K (phytonadione) and fresh frozen plasma (FFP) or
prothrombin complex concentrate (PCC)
C) Start a direct oral anticoagulant (DOAC)
D) Administer protamine sulfate
Correct Answer: B) Administer vitamin K (phytonadione) and fresh frozen
plasma (FFP) or prothrombin complex concentrate (PCC)
